Investors & Media Search: Select: Select Current Company News News archive 2019 News archive 2018 News archive 2017 News archive 2016 News archive 2015 News archive 2014 News archive 2013 News archive 2012 News archive 2011 News archive 2010 News archive 2009 News archive 2008 News archive 2007 News archive 2006 Oct 23, 2008International Stem Cell Corporation Releases Letter to Shareholders Oct 22, 2008International Stem Cell Corporation Retains The Investor Relations Group Oct 16, 2008International Stem Cell Corporation Names Rouslan Semechkin to Board of Directors Aug 21, 2008International Stem Cell Corporation Arranges $ 3 Million Equity Financing Jul 17, 2008International Stem Cell Corporation and Novocell, Inc. Collaborate to Test Human Parthenogenetic Stem Cells for production of Pancreatic Islet Cells that may be useful in the Treatment of Diabetes Jul 08, 2008International Stem Cell Corporation Announces Collaboration with Michigan State University to Study Parthenogenetic Stem Cells Jun 25, 2008International Stem Cell Corporation Signs Agreement with BioTime, Inc., and Embryome Sciences, Inc., to Provide Unique Human Stem Cell Lines for Research Use May 14, 2008International Stem Cell Corporation's Human Parthenogenetic Stem Cells to be used in the Development of Treatments for Liver Disease Apr 29, 2008International Stem Cell Corporation Obtains Exclusive Rights in the US and Canada to Distribute Approved Human Skin Model for Toxicity Testing Apr 25, 2008International Stem Cell Corporation to Present at LD Micro Conference April 29, 2008 25 26 27 28 29 30 31 32 33 << < > >>